Product Information
LABETALOL HCL 300 MG TABLET is a generic product labeled by Method Pharmaceuticals LLC, priced at $0.2086 per EA under NDC 58657060401. Its NADAC has been published 333 times since Feb 12, 2020.
Strength
300 mg/1
Manufacturer
Method Pharmaceuticals LLCNDC
58657060401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LABETALOLApproval Type
Generic (ANDA)
FDA Application
ANDA075215On Market Since
11/22/2019
Pharmacological Classes
Price Statistics
The NADAC for LABETALOL HCL 300 MG TABLET has been published 333 times since Feb 12, 2020, and over the history we have for it it has declined 32.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2086 per EA |
|---|---|
| All-time high | $0.3238 (Jun 10, 2020) |
| All-time low | $0.1776 (Nov 20, 2024) |
| 52-week high | $0.2117 |
| 52-week low | $0.1998 |
| Median price | $0.2140 |
| Average price | $0.2245 |
| Largest weekly change | +21.9% (Feb 17, 2021) |
| Weeks tracked | 333 |
| Tracking since | Feb 12, 2020 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LABETALOL HCL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 300 MG TABLET, manufactured by Method Pharmaceuticals LLC, is $0.2086 per EA (NDC 58657060401), effective Jun 24, 2026.
How has the price of LABETALOL HCL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LABETALOL HCL 300 MG TABLET has declined 32.5%. It has been tracked across 333 weekly CMS publications since Feb 12, 2020.
What are the highest and lowest recorded NADAC prices for LABETALOL HCL 300 MG TABLET?
Since Feb 12, 2020, the NADAC for LABETALOL HCL 300 MG TABLET has ranged from a low of $0.1776 (Nov 20, 2024) to a high of $0.3238 (Jun 10, 2020), with a median of $0.2140 per EA.
Are there cheaper alternatives to LABETALOL HCL 300 MG TABLET?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LABETALOL HCL 300 MG TABLET, is $0.2041 per EA — about 2% below LABETALOL HCL 300 MG TABLET.
Who manufactures LABETALOL HCL 300 MG TABLET?
LABETALOL HCL 300 MG TABLET (NDC 58657060401) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification